The possibilities of using sodium-glucose cotransporter type 2 inhibitors in the treatment of patients with cardiovascular diseases (literature review)
Myocardial infarction remains one of the most common causes of chronic heart failure. Modern innovative treatment of patients with high cardiovascular risk is the use of sodium-glucose cotransporter type 2 inhibitors - a class of antidiabetic drugs. This review is devoted to the study of dapaglifl...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Penza State University Publishing House
2024-03-01
|
| Series: | Известия высших учебных заведений. Поволжский регион: Медицинские науки |
| Subjects: |